Cargando…

Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1

PURPOSE: Exosomal microRNAs (miRNAs) play essential roles in the development of hepatocellular carcinoma (HCC). Nevertheless, the role and mechanism of exosomal miR-638 in HCC development remain largely unknown. METHODS: Exosomes were isolated and confirmed via transmission electron microscopy and w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jing, Li, Bo, Zhao, Shuo, Du, Hongyu, Du, Yaming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368457/ https://www.ncbi.nlm.nih.gov/pubmed/32764961 http://dx.doi.org/10.2147/OTT.S253151

Ejemplares similares

Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction]
Publicado: (2021)

Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients
por: Yan, Shushan, et al.
Publicado: (2017)

Methylation-associated silencing of miR-638 promotes endometrial carcinoma progression by targeting MEF2C
por: Ni, Jianjiao, et al.
Publicado: (2020)

Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma
por: Wan, Yong, et al.
Publicado: (2017)

Exosomal miRNA Expression Profiling and the Roles of Exosomal miR-4741, miR-32, miR-3149, and miR-6727 on Gastric Cancer Progression
por: Tang, Guojun, et al.
Publicado: (2022)

Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients
por: Li, Minghong, et al.
Publicado: (2018)

MiR-638 acts as a tumor suppressor gene in gastric cancer
por: Shen, Yu, et al.
Publicado: (2017)

Dysregulation of miR-638 in diabetic nephropathy and its role in inflammatory response
por: Lin, Mei, et al.
Publicado: (2021)

miR-638 regulates gene expression networks associated with emphysematous lung destruction
por: Christenson, Stephanie A, et al.
Publicado: (2013)

MiR-638 Repressed Vascular Smooth Muscle Cell Glycolysis by Targeting LDHA
por: Chen, Shiyuan, et al.
Publicado: (2019)

Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis
por: Hu, Lixia, et al.
Publicado: (2021)

Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells
por: Yokota, Yuki, et al.
Publicado: (2021)

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF
por: Cheng, Jiwen, et al.
Publicado: (2016)

Hsa_circ_0043278 functions as competitive endogenous RNA to enhance glioblastoma multiforme progression by sponging miR-638
por: Wu, Zhi, et al.
Publicado: (2020)

Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression
por: Xu, Pei, et al.
Publicado: (2020)

miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy
por: Bhattacharya, Animesh, et al.
Publicado: (2014)

Secretion of small/microRNAs including miR-638 into extracellular spaces by sphingomyelin phosphodiesterase 3
por: KUBOTA, SHIORI, et al.
Publicado: (2015)

miR-638 Serves as a Biomarker of 5-Fluorouracil Sensitivity to Neoadjuvant Chemotherapy in Breast Cancer
por: Wang, Bin, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Fründt, Thorben, et al.
Publicado: (2021)

Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2
por: Wang, Guanghui, et al.
Publicado: (2019)

Delivery of miR-26a Using an Exosomes-Based Nanosystem Inhibited Proliferation of Hepatocellular Carcinoma
por: Mahati, Shaya, et al.
Publicado: (2021)

Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (Review)
por: Thapa, Nikita, et al.
Publicado: (2022)

CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer
por: Hu, Peng-Chao, et al.
Publicado: (2019)

MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients
por: Yuan, Bo, et al.
Publicado: (2015)

Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma
por: Elghoroury, Eman A, et al.
Publicado: (2022)

miR-638 suppresses DNA damage repair by targeting SMC1A expression in terminally differentiated cells
por: He, Mingyang, et al.
Publicado: (2016)

miR-638 suppresses proliferation by negatively regulating high mobility group A1 in ovarian cancer cells
por: Ma, Li, et al.
Publicado: (2021)

Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2021)

Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma
por: Sun, Li, et al.
Publicado: (2021)

miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3
por: Zhou, Hongyu, et al.
Publicado: (2022)

miR-136 Inhibits Malignant Progression of Hepatocellular Carcinoma Cells by Targeting Cyclooxygenase 2
por: Jia, Haiyan, et al.
Publicado: (2018)

Exosomal miR-29b from cancer-associated fibroblasts inhibits the migration and invasion of hepatocellular carcinoma cells
por: Liu, Xingchao, et al.
Publicado: (2020)

Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells
por: Ma, Kelong, et al.
Publicado: (2014)

miR‐206 inhibits the growth of hepatocellular carcinoma cells via targeting CDK9
por: Pang, Chi, et al.
Publicado: (2017)

miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy
por: Wang, Fang, et al.
Publicado: (2015)

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma
por: Liu, Weifeng, et al.
Publicado: (2017)

Downregulation of serum exosomal miR‐320d predicts poor prognosis in hepatocellular carcinoma
por: Li, Wenxiao, et al.
Publicado: (2020)

Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1
por: Wang, Qiong, et al.
Publicado: (2021)

MicroRNA‐638 inhibits human aortic valve interstitial cell calcification by targeting Sp7
por: Jiao, Wenjie, et al.
Publicado: (2019)

Circular RNA circ_0001459 accelerates hepatocellular carcinoma progression via the miR‐6165/IGF1R axis
por: Shen, Duo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cohj78k6j4sjs9voerde6vv5p7